Moderna, Pfizer Reveal COVID-19 Vaccine Trial Blueprints

Medicine & Technology Sep 18, 2020

American drug companies Moderna and Pfizer have disclosed its secret blueprints in their respective coronavirus disease (COVID-19) vaccine trials in a move to gain the confidence of the clamoring public and scientific communities.

COVID-19 Vaccines May Damage Human DNA

Aug 07, 2020

The FDA 'Fast Track' designation may not be as safe as people may believe, warns a medical expert. The cost the people may be paying for vaccines may be a permanent alternation in their DNA.

Moderna Announced Partnership With Amazon Web Services for Their Analytics and Machine Learning Services

Aug 06, 2020

Moderna, the biotech company just signed a big cloud deal with Amazon Web Services that will provide its standard platform for doing analytics and machine learning as they continue to develop COVID-19 vaccines.

Is Moderna Coronavirus Vaccine Leading the Race? Early Trials Show the Jab Gives Off Immunity

Jul 15, 2020

There's good news from Moderna's mRNA-1273 coronavirus vaccine candidate. A preliminary report states that all 45 volunteers in its clinical trial developed immunity to the coronavirus with no adverse reactions.

Volunteer Suffered 'Severe Reaction' in Moderna Therapeutics' Coronavirus Vaccine Trial

May 27, 2020

Ian Haydon was among the three volunteers given the highest dose of the candidate vaccine from Moderna Therapeutics. He had adverse reactions, while another was given a lower dose and developed a rash.

Moderna’s COVID-19 Vaccine Dubious? Experts Demand Concrete Data Not Mere Words

May 19, 2020

Vaccine experts are skeptical of Moderna's vaccine candidate. On Monday, the company released information regarding their vaccine developing an immune response in their subjects. Other researchers, seemingly, have further questions to ask. Click the link above to read more.

'Very Low' Dose Moderna COVID-19 Vaccine Elicits Immune Response With No Side Effect, First Human Trial Show

May 18, 2020

American biotechnology company Moderna announces that the first phase of its clinical trial is "generally safe and well-tolerated."

Production of the First Batch of Proposed COVID-19 Vaccines in the US Expected in July

May 01, 2020

Moderna, Inc. and Lonza Group AG partnered to manufacture one billion doses of the first proposed vaccine for the coronavirus disease 2019 (COVID-19). It's expected in July because Moderna already had a headstart on studying the coronavirus.